Information about Alzheimer's disease co-pathology was not available for this study; however, we speculate that the unclassifiable patients with DLB or iRBD could reflect a “pure” alpha-synuclein phenotype with limited co-pathology, with consequently a lesser degree of atrophy. The gene discussed is SNCA; the disease is early-onset autosomal dominant Alzheimer disease.